Increased constitutive expression of VEGF observed in untreated PsA SFC-CM compared to RA SFC-CM partly explains the observed differences in pro-angiogenic activity of the SFC-CM-treated endothelial cells. This evidence concerns the gene VEGFA and rheumatoid arthritis.